
Personalized Testing And Supplements Global Market Report 2025
Description
Personalized Testing And Supplements Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on personalized testing and supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Where is the largest and fastest growing market for personalized testing and supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized testing and supplements market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Markets Covered:1) By Service: Personalized Testing; Personalized Recommendations; Personalized Supplements
2) By Service Provider: Personalized Testing And Supplement Companies (DTC); Dieticians And Nutritionists; Others Service Providers
3) By Application: General Health And Wellness; Deficiency Management; Other Application
Subsegments:
1) By Personalized Testing: Genetic Testing; Diagnostic Testing; Microbiome Testing; Nutritional Testing; Metabolic Testing
2) By Personalized Recommendations: Diet And Nutrition Recommendations; Fitness And Exercise Recommendations; Wellness And Lifestyle Recommendations; Healthcare And Medical Recommendations
3) By Personalized Supplements: Custom Vitamin Blends; Personalized Protein Supplements; Targeted Mineral Supplements; Gut Health Supplements; Personalized Beauty Supplements
Companies Mentioned: DSM-Firmenich; Nestlé Health Science S.A.; GNC Holdings Inc.; The Vitamin Shoppe Inc.; Pharmavite LLC; Baze Personalized Nutrition; Metagenetics Inc.; Thorne HealthTech Inc.; Loewi Inc.; Everlywell Inc.; Nutrafol Inc.; Vitl Health Ltd.; Viome Life Sciences Inc.; InsideTracker Inc.; Bioniq Health Ltd.; LifeNome Inc.; Biohm Health; Rootine Health Inc.; Panaceutics Inc.; Elo Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
This report focuses on personalized testing and supplements market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for personalized testing and supplements ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The personalized testing and supplements market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Markets Covered:1) By Service: Personalized Testing; Personalized Recommendations; Personalized Supplements
2) By Service Provider: Personalized Testing And Supplement Companies (DTC); Dieticians And Nutritionists; Others Service Providers
3) By Application: General Health And Wellness; Deficiency Management; Other Application
Subsegments:
1) By Personalized Testing: Genetic Testing; Diagnostic Testing; Microbiome Testing; Nutritional Testing; Metabolic Testing
2) By Personalized Recommendations: Diet And Nutrition Recommendations; Fitness And Exercise Recommendations; Wellness And Lifestyle Recommendations; Healthcare And Medical Recommendations
3) By Personalized Supplements: Custom Vitamin Blends; Personalized Protein Supplements; Targeted Mineral Supplements; Gut Health Supplements; Personalized Beauty Supplements
Companies Mentioned: DSM-Firmenich; Nestlé Health Science S.A.; GNC Holdings Inc.; The Vitamin Shoppe Inc.; Pharmavite LLC; Baze Personalized Nutrition; Metagenetics Inc.; Thorne HealthTech Inc.; Loewi Inc.; Everlywell Inc.; Nutrafol Inc.; Vitl Health Ltd.; Viome Life Sciences Inc.; InsideTracker Inc.; Bioniq Health Ltd.; LifeNome Inc.; Biohm Health; Rootine Health Inc.; Panaceutics Inc.; Elo Health Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
Table of Contents
250 Pages
- 1. Executive Summary
- 2. NGS Oncology Market Characteristics
- 3. NGS Oncology Market Trends And Strategies
- 4. NGS Oncology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
- 4.1. Supply Chain Impact from Tariff War & Trade Protectionism
- 5. Global NGS Oncology Growth Analysis And Strategic Analysis Framework
- 5.1. Global NGS Oncology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
- 5.2. Analysis Of End Use Industries
- 5.3. Global NGS Oncology Market Growth Rate Analysis
- 5.4. Global NGS Oncology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
- 5.5. Global NGS Oncology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
- 5.6. Global NGS Oncology Total Addressable Market (TAM)
- 6. NGS Oncology Market Segmentation
- 6.1. Global NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Targeted Sequencing
- Genomics
- Transcriptomics
- Epigenomics
- 6.2. Global NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Platform
- Kits
- Services
- 6.3. Global NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Pre-Sequencing
- Sequencing
- Data Analysis
- 6.4. Global NGS Oncology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Genetic Screening
- Hereditary Genetic Testing
- Hematological Malignancies
- Solid Tumors
- Other Applications
- 6.5. Global NGS Oncology Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Hospitals And Clinics
- Clinical Research Organizations (CROs)
- Academic And Research Institutes
- Pharmaceutical And Biotechnology Companies
- Other End Users
- 6.6. Global NGS Oncology Market, Sub-Segmentation Of Targeted Sequencing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Whole Exome Sequencing (WES)
- Amplicon-Based Sequencing
- Hybridization-Based Sequencing
- 6.7. Global NGS Oncology Market, Sub-Segmentation Of Genomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- Whole Genome Sequencing (WGS)
- Structural Variant Detection
- Copy Number Variation (CNV) Analysis
- 6.8. Global NGS Oncology Market, Sub-Segmentation Of Transcriptomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- RNA Sequencing
- Single-Cell Transcriptomics
- Non-coding RNA Analysis
- 6.9. Global NGS Oncology Market, Sub-Segmentation Of Epigenomics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- DNA Methylation Sequencing
- Chromatin Immunoprecipitation Sequencing
- Histone Modification Analysis
- 7. NGS Oncology Market Regional And Country Analysis
- 7.1. Global NGS Oncology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 7.2. Global NGS Oncology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8. Asia-Pacific NGS Oncology Market
- 8.1. Asia-Pacific NGS Oncology Market Overview
- Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.3. Asia-Pacific NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 8.4. Asia-Pacific NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 9. China NGS Oncology Market
- 9.1. China NGS Oncology Market Overview
- 9.2. China NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.3. China NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 9.4. China NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
- 10. India NGS Oncology Market
- 10.1. India NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.2. India NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 10.3. India NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11. Japan NGS Oncology Market
- 11.1. Japan NGS Oncology Market Overview
- 11.2. Japan NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.3. Japan NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 11.4. Japan NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12. Australia NGS Oncology Market
- 12.1. Australia NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.2. Australia NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 12.3. Australia NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13. Indonesia NGS Oncology Market
- 13.1. Indonesia NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.2. Indonesia NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 13.3. Indonesia NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14. South Korea NGS Oncology Market
- 14.1. South Korea NGS Oncology Market Overview
- 14.2. South Korea NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.3. South Korea NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 14.4. South Korea NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15. Western Europe NGS Oncology Market
- 15.1. Western Europe NGS Oncology Market Overview
- 15.2. Western Europe NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.3. Western Europe NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 15.4. Western Europe NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16. UK NGS Oncology Market
- 16.1. UK NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.2. UK NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 16.3. UK NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17. Germany NGS Oncology Market
- 17.1. Germany NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.2. Germany NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 17.3. Germany NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18. France NGS Oncology Market
- 18.1. France NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.2. France NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 18.3. France NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19. Italy NGS Oncology Market
- 19.1. Italy NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.2. Italy NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 19.3. Italy NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20. Spain NGS Oncology Market
- 20.1. Spain NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.2. Spain NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 20.3. Spain NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21. Eastern Europe NGS Oncology Market
- 21.1. Eastern Europe NGS Oncology Market Overview
- 21.2. Eastern Europe NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.3. Eastern Europe NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 21.4. Eastern Europe NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22. Russia NGS Oncology Market
- 22.1. Russia NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.2. Russia NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 22.3. Russia NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23. North America NGS Oncology Market
- 23.1. North America NGS Oncology Market Overview
- 23.2. North America NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.3. North America NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 23.4. North America NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24. USA NGS Oncology Market
- 24.1. USA NGS Oncology Market Overview
- 24.2. USA NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.3. USA NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 24.4. USA NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25. Canada NGS Oncology Market
- 25.1. Canada NGS Oncology Market Overview
- 25.2. Canada NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.3. Canada NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 25.4. Canada NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26. South America NGS Oncology Market
- 26.1. South America NGS Oncology Market Overview
- 26.2. South America NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.3. South America NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 26.4. South America NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27. Brazil NGS Oncology Market
- 27.1. Brazil NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.2. Brazil NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 27.3. Brazil NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28. Middle East NGS Oncology Market
- 28.1. Middle East NGS Oncology Market Overview
- 28.2. Middle East NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.3. Middle East NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 28.4. Middle East NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29. Africa NGS Oncology Market
- 29.1. Africa NGS Oncology Market Overview
- 29.2. Africa NGS Oncology Market, Segmentation By Sequencing Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.3. Africa NGS Oncology Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 29.4. Africa NGS Oncology Market, Segmentation By Workflow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
- 30. NGS Oncology Market Competitive Landscape And Company Profiles
- 30.1. NGS Oncology Market Competitive Landscape
- 30.2. NGS Oncology Market Company Profiles
- 30.2.1. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Eurofins Scientific SE Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
- 31. NGS Oncology Market Other Major And Innovative Companies
- 31.1. Qiagen N.V.
- 31.2. Tecan Trading AG
- 31.3. Myriad Genetics
- 31.4. Takara Bio Inc.
- 31.5. Beijing Genomics Institute (BGI)
- 31.6. Caris Life Sciences
- 31.7. Foundation Medicine
- 31.8. Paradigm Diagnostics
- 31.9. Pacific Bioscience
- 31.10. Horizon Discovery Group plc
- 31.11. Creative-Biolabs
- 31.12. Xcelris Labs Ltd.
- 31.13. Partek Inc.
- 31.14. 4baseCare
- 31.15. SciGenom Labs Pvt. Ltd.
- 32. Global NGS Oncology Market Competitive Benchmarking And Dashboard
- 33. Key Mergers And Acquisitions In The NGS Oncology Market
- 34. Recent Developments In The NGS Oncology Market
- 35. NGS Oncology Market High Potential Countries, Segments and Strategies
- 35.1 NGS Oncology Market In 2029 - Countries Offering Most New Opportunities
- 35.2 NGS Oncology Market In 2029 - Segments Offering Most New Opportunities
- 35.3 NGS Oncology Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.